Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06423365 · ClinicalTrials.gov registry record · NA
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
A NA study of Cardiovascular Diseases and Hypercholesterolemia, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 816
- Enrollment target
- 1
- Study location
NCT06423365: Active NA study of Cardiovascular Diseases and Hypercholesterolemia, sponsored by University of Utah.
NCT06423365 is a NA study of Cardiovascular Diseases and Hypercholesterolemia that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 816 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06423365, a NA study of Cardiovascular Diseases and Hypercholesterolemia, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 816 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if an educational website can help patients make an informed decision and engage in shared decision-making with their healthcare provider regarding cholesterol lowering medication use after they have stopped statin therapy due to self-reported muscle symptoms from taking a statin medication. The main questions the trial aims to answer are: 1. Compared to usual care, are patients who engage with the website after experiencing statin-associated muscle symptoms (SAMS) more likely to retry statin therapy? 2. Compared to usual care, are patients who retry statin therapy after engaging with the website more likely to persist on statin therapy? Researchers will compare people randomized to use the website to those who are receiving usual care to see if statin re-start and persistence rates change. All participants will take baseline questionnaires and receive usual care as they would if they were not in the study (e.g., visit their doctor, get labs drawn, take medication as prescribed). Patients randomized to the website arm will be asked to engage with content in a website which is anticipated to take most patients approximately 30-minutes. Their clinician will then contact them for a follow-up visit as needed.
Primary Outcome
Measured using pharmacy dispensing records
Conditions Studied
Interventions
- OTHER Virtual Statin Management (VSM)
Study Locations (1)
Colorado
- Kaiser Permanente Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 816 participants |
| Start Date | 2024-10-24 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What the registry record for NCT06423365 still lists
NCT06423365 is an interventional study that assigns participants to a tested intervention. The registered 816 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Virtual Statin Management (VSM) is the first listed.
NCT06423365 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06423365 about?
NCT06423365 is a clinical study titled "A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.". The goal of this clinical trial is to learn if an educational website can help patients make an informed decision and engage in shared decision-making with their healthcare provider regarding cholesterol lowering medication use after they have stopped statin therapy due to self-reported muscle sympt...
What is the current status of trial NCT06423365?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 816 participants. The study started on 2024-10-24. Estimated completion is 2026-05-01.
What conditions does trial NCT06423365 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Hypercholesterolemia, Placebo Effect, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pharmacists.
What interventions are being tested in trial NCT06423365?
The interventions under investigation include: Virtual Statin Management (VSM) (OTHER).
Who is sponsoring clinical trial NCT06423365?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06423365 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06423365's enrollment target sits among peer trials
816 68th of 300 higher than 233 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI